These findings suggest that IGF-I therapy appears as an appropriate treatment in hypogonadism only when this is associated to conditions of IGF-I deficiency (such as Laron Syndrom or liver cirrhosis). This evidence concerns the gene IGF1 and hyperinsulinemic hypoglycemia, familial, 4.